NSC 637037
Showing 1 - 25 of 46
DLBCL (DLBCL), Primary Mediastinal Large B-cell Lymphoma, Burkitt Lymphoma Trial run by the National Cancer Institute (NCI)
Active, not recruiting
- Diffuse Large B-Cell Lymphoma (DLBCL)
- +4 more
- EPOCH
- Rituximab
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte
Withdrawn
- Recurrent Anaplastic Astrocytoma
- +7 more
- Neural Stem Cells-expressing CRAd-S-pk7
- Resection
- (no location specified)
Nov 22, 2022
Dementia Trial in Málaga (Nordic Sensi Chair)
Completed
- Dementia
- Nordic Sensi Chair
-
Málaga, SpainInstituto Andaluz de Neurociencia
Jan 30, 2023
Glioblastoma Multiforme, Anaplastic Astrocytoma, Gliosarcoma Trial in Birmingham (M032, Pembrolizumab)
Recruiting
- Glioblastoma Multiforme
- +2 more
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Jan 30, 2023
On Craniosynostosis, Skull Malformations With Premature Fusion
Recruiting
- Craniosynostosis
- Craniosynostosis Network Environmental Survey
- +6 more
-
Davis, California
- +19 more
Jul 5, 2022
From Skin Fibroblasts to Neural Stem Cells to Investigate in
Active, not recruiting
- Diabetes Mellitus, Type 2
- +5 more
- Skin biopsy
-
Roma, ItalyMingrone Geltrude
Mar 8, 2023
NSCLC, Bone Metastases Trial in France (Denosumab-nivolumab combination)
Active, not recruiting
- Carcinoma, Non-Small-Cell Lung
- Bone Metastases
- Denosumab-nivolumab combination
-
Aix-en-Provence, France
- +26 more
Jul 19, 2022
Executive Function of School-aged Children With ASD Trial in Taipei City (VR game intervention)
Recruiting
- Executive Function of School-aged Children With ASD
- VR game intervention
-
Taipei City, State, TaiwanNational Taiwan Normal University
Nov 12, 2023
Complex Post-Traumatic Stress Disorder Trial in Leatherhead (Enhanced Skills Training in Affective and Interpersonal Regulation,
Recruiting
- Complex Post-Traumatic Stress Disorder
- Enhanced Skills Training in Affective and Interpersonal Regulation
- Treatment as usual
-
Leatherhead, Surrey, United KingdomCombat Stress
Apr 22, 2022
Parkinson Disease Trial in Rouen (Directional and single ring STN-DBS on gait)
Unknown status
- Parkinson Disease
- Directional and single ring STN-DBS on gait
-
Rouen, FranceCHU de ROUEN
Jun 2, 2020
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Recurrent Colon Cancer Trial in Houston (saracatinib, laboratory
Terminated
- Adenocarcinoma of the Colon
- +5 more
- saracatinib
- laboratory biomarker analysis
-
Houston, TexasM D Anderson Cancer Center
Jul 29, 2019
Child Behavior, Autism Spectrum Disorder, Psychiatric Hospitalization Trial (Activity)
Completed
- Child Behavior
- +3 more
- Activity
- (no location specified)
May 16, 2019
Parkinson Disease Trial in Suzhou (human neural stem cell)
Unknown status
- Parkinson Disease
- human neural stem cell
-
Suzhou, Jiangsu, ChinaDepartment of Neurology, Second Affiliated Hospital of Soochow U
Sep 13, 2017
Neurofibromatosis, Neurofibromas Trial in Indianapolis (Gleevec)
Completed
- Neurofibromatosis
- Neurofibromas
-
Indianapolis, IndianaRiley Hospital for Children
Jun 2, 2017
Non-Small-Cell Lung Carcinoma, Prostate Cancer, Bladder Cancer Trial in Ann Arbor (vorinostat (suberoylanilide hydroxamic acid),
Terminated
- Non-Small-Cell Lung Carcinoma
- +3 more
- vorinostat (suberoylanilide hydroxamic acid)
- docetaxel
-
Ann Arbor, MichiganUniversity of Michigan Comprehensive Cancer Center
Dec 1, 2016
Cutaneous T Cell Lymphoma, Peripheral T Cell Lymphoma Trial in Australia, United States (Romidepsin)
Completed
- Cutaneous T Cell Lymphoma
- Peripheral T Cell Lymphoma
-
Scottsdale, Arizona
- +12 more
Apr 13, 2017
Multiple Myeloma Trial in Riyadh (Lenalidomide/Low dose Dex, Bortezomib/Lenalidomide/ Low dose Dex, Lenalidomide)
Completed
- Multiple Myeloma
- Lenalidomide/Low dose Dex
- +2 more
-
Riyadh, Saudi ArabiaKing Faisal Specialist Hospital &Reseach Center
Feb 24, 2016
Glioblastoma, Gliosarcoma Trial in Durham (Temodar and O6-Benzylguanine)
Completed
- Glioblastoma
- Gliosarcoma
- Temodar and O6-Benzylguanine
-
Durham, North CarolinaDuke University Health System
Jul 15, 2014
Glioblastoma Multiforme, Anaplastic Glioma Trial in Durham (Temodar and O6-Benzylguanine (BG))
Completed
- Glioblastoma Multiforme
- Anaplastic Glioma
- Temodar and O6-Benzylguanine (BG)
-
Durham, North CarolinaDuke University Health System
Jul 8, 2014
Lung Cancer, Breast Cancer, Prostate Cancer Trial in Richmond (Radiotherapy)
Terminated
- Lung Cancer
- +2 more
- Radiotherapy
-
Richmond, VirginiaMassey Cancer Center/Virginia Commonwealth University
May 15, 2015
Biomarker-enhanced ED Disposition Decisions
Completed
- Non-specific Complaints
- biomarker-enhanced disposition decision with proADM
-
Basel, SwitzerlandUniversity Hospital Basel
Dec 12, 2014
Glioblastoma, Gliosarcoma Trial in Durham (Temodar, O6-BG, and Irinotecan)
Completed
- Glioblastoma
- Gliosarcoma
- Temodar, O6-BG, and Irinotecan
-
Durham, North CarolinaDuke University Health System
Jun 18, 2013
Brain and CNS Tumors Trial in Durham (O6-benzylguanine, temozolomide, conventional surgery)
Completed
- Brain and Central Nervous System Tumors
- O6-benzylguanine
- +2 more
-
Durham, North CarolinaDuke Comprehensive Cancer Center
Jun 19, 2013